The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Blood Lancet Market Research Report 2024
Synopsis
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
Global Medical Blood Lancet market is projected to reach US$ 2628.2 million in 2029, increasing from US$ 1857 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Blood Lancet market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Blood Lancet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets
Ordinary Lancets
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Blood Lancet report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
Global Medical Blood Lancet market is projected to reach US$ 2628.2 million in 2029, increasing from US$ 1857 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Blood Lancet market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Blood Lancet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets
Ordinary Lancets
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Blood Lancet report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medical Blood Lancet Market Overview
1.1 Product Overview and Scope of Medical Blood Lancet
1.2 Medical Blood Lancet Segment by Type
1.2.1 Global Medical Blood Lancet Market Value Comparison by Type (2023-2029)
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Medical Blood Lancet Segment by Application
1.3.1 Global Medical Blood Lancet Market Value by Application: (2023-2029)
1.3.2 Hospital & Clinics
1.3.3 Home
1.3.4 Other
1.4 Global Medical Blood Lancet Market Size Estimates and Forecasts
1.4.1 Global Medical Blood Lancet Revenue 2018-2029
1.4.2 Global Medical Blood Lancet Sales 2018-2029
1.4.3 Global Medical Blood Lancet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Blood Lancet Market Competition by Manufacturers
2.1 Global Medical Blood Lancet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Blood Lancet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Blood Lancet Average Price by Manufacturers (2018-2023)
2.4 Global Medical Blood Lancet Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Blood Lancet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Blood Lancet, Product Type & Application
2.7 Medical Blood Lancet Market Competitive Situation and Trends
2.7.1 Medical Blood Lancet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Blood Lancet Players Market Share by Revenue
2.7.3 Global Medical Blood Lancet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Blood Lancet Retrospective Market Scenario by Region
3.1 Global Medical Blood Lancet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Blood Lancet Global Medical Blood Lancet Sales by Region: 2018-2029
3.2.1 Global Medical Blood Lancet Sales by Region: 2018-2023
3.2.2 Global Medical Blood Lancet Sales by Region: 2024-2029
3.3 Global Medical Blood Lancet Global Medical Blood Lancet Revenue by Region: 2018-2029
3.3.1 Global Medical Blood Lancet Revenue by Region: 2018-2023
3.3.2 Global Medical Blood Lancet Revenue by Region: 2024-2029
3.4 North America Medical Blood Lancet Market Facts & Figures by Country
3.4.1 North America Medical Blood Lancet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Blood Lancet Sales by Country (2018-2029)
3.4.3 North America Medical Blood Lancet Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Blood Lancet Market Facts & Figures by Country
3.5.1 Europe Medical Blood Lancet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Blood Lancet Sales by Country (2018-2029)
3.5.3 Europe Medical Blood Lancet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Blood Lancet Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Blood Lancet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Blood Lancet Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Blood Lancet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Blood Lancet Market Facts & Figures by Country
3.7.1 Latin America Medical Blood Lancet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Blood Lancet Sales by Country (2018-2029)
3.7.3 Latin America Medical Blood Lancet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Blood Lancet Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Blood Lancet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Blood Lancet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Blood Lancet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Blood Lancet Sales by Type (2018-2029)
4.1.1 Global Medical Blood Lancet Sales by Type (2018-2023)
4.1.2 Global Medical Blood Lancet Sales by Type (2024-2029)
4.1.3 Global Medical Blood Lancet Sales Market Share by Type (2018-2029)
4.2 Global Medical Blood Lancet Revenue by Type (2018-2029)
4.2.1 Global Medical Blood Lancet Revenue by Type (2018-2023)
4.2.2 Global Medical Blood Lancet Revenue by Type (2024-2029)
4.2.3 Global Medical Blood Lancet Revenue Market Share by Type (2018-2029)
4.3 Global Medical Blood Lancet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Blood Lancet Sales by Application (2018-2029)
5.1.1 Global Medical Blood Lancet Sales by Application (2018-2023)
5.1.2 Global Medical Blood Lancet Sales by Application (2024-2029)
5.1.3 Global Medical Blood Lancet Sales Market Share by Application (2018-2029)
5.2 Global Medical Blood Lancet Revenue by Application (2018-2029)
5.2.1 Global Medical Blood Lancet Revenue by Application (2018-2023)
5.2.2 Global Medical Blood Lancet Revenue by Application (2024-2029)
5.2.3 Global Medical Blood Lancet Revenue Market Share by Application (2018-2029)
5.3 Global Medical Blood Lancet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Medical Blood Lancet Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BD Medical Blood Lancet Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Ascensia
6.3.1 Ascensia Corporation Information
6.3.2 Ascensia Description and Business Overview
6.3.3 Ascensia Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ascensia Medical Blood Lancet Product Portfolio
6.3.5 Ascensia Recent Developments/Updates
6.4 Lifescan
6.4.1 Lifescan Corporation Information
6.4.2 Lifescan Description and Business Overview
6.4.3 Lifescan Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lifescan Medical Blood Lancet Product Portfolio
6.4.5 Lifescan Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Medical Blood Lancet Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Medical Blood Lancet Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nipro Medical Blood Lancet Product Portfolio
6.7.5 Nipro Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cardinal Health Medical Blood Lancet Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ARKRAY Medical Blood Lancet Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Corporation Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ICU Medical Medical Blood Lancet Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Medical Blood Lancet Description and Business Overview
6.11.3 Owen Mumford Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Owen Mumford Medical Blood Lancet Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 HemoCue
6.12.1 HemoCue Corporation Information
6.12.2 HemoCue Medical Blood Lancet Description and Business Overview
6.12.3 HemoCue Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.12.4 HemoCue Medical Blood Lancet Product Portfolio
6.12.5 HemoCue Recent Developments/Updates
6.13 Greiner Bio One
6.13.1 Greiner Bio One Corporation Information
6.13.2 Greiner Bio One Medical Blood Lancet Description and Business Overview
6.13.3 Greiner Bio One Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Greiner Bio One Medical Blood Lancet Product Portfolio
6.13.5 Greiner Bio One Recent Developments/Updates
6.14 HTL-STREFA
6.14.1 HTL-STREFA Corporation Information
6.14.2 HTL-STREFA Medical Blood Lancet Description and Business Overview
6.14.3 HTL-STREFA Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.14.4 HTL-STREFA Medical Blood Lancet Product Portfolio
6.14.5 HTL-STREFA Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Corporation Information
6.15.2 Sarstedt Medical Blood Lancet Description and Business Overview
6.15.3 Sarstedt Medical Blood Lancet Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sarstedt Medical Blood Lancet Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Blood Lancet Industry Chain Analysis
7.2 Medical Blood Lancet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Blood Lancet Production Mode & Process
7.4 Medical Blood Lancet Sales and Marketing
7.4.1 Medical Blood Lancet Sales Channels
7.4.2 Medical Blood Lancet Distributors
7.5 Medical Blood Lancet Customers
8 Medical Blood Lancet Market Dynamics
8.1 Medical Blood Lancet Industry Trends
8.2 Medical Blood Lancet Market Drivers
8.3 Medical Blood Lancet Market Challenges
8.4 Medical Blood Lancet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
